Cargando…
Induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic apoptotic pathways in primary effusion lymphoma
Primary effusion lymphoma (PEL) is an incurable non-Hodgkin's lymphoma and novel biology-based treatments are urgently needed in clinical settings. Shikonin (SHK), a napthoquinone derivative, has been used for the treatment of solid tumors. Here, we report that SHK is an effective agent for the...
Autores principales: | Alam, Md Masud, Kariya, Ryusho, Boonnate, Piyanard, Kawaguchi, Azusa, Okada, Seiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785961/ https://www.ncbi.nlm.nih.gov/pubmed/33401054 http://dx.doi.org/10.1016/j.tranon.2020.101006 |
Ejemplares similares
-
Shikonin Induces ROS-Dependent Apoptosis Via Mitochondria Depolarization and ER Stress in Adult T Cell Leukemia/Lymphoma
por: Boonnate, Piyanard, et al.
Publicado: (2023) -
ROS mediated apoptotic pathways in primary effusion lymphoma: Comment on induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic pathways in primary effusion lymphoma
por: Dwivedi, Pankaj
Publicado: (2021) -
Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1-related anti-apoptotic proteins
por: Saranaruk, Paksiree, et al.
Publicado: (2020) -
Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models
por: Okada, Seiji, et al.
Publicado: (2019) -
Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor
por: Obchoei, Sumalee, et al.
Publicado: (2022)